Steven Cohen Regulus Therapeutics Inc. Transaction History
Point72 Asset Management, L.P.
- $36.6 Billion
- Q3 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 893,762 shares of RGLS stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
893,762Holding current value
$1.34 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RGLS
# of Institutions
74Shares Held
56.5MCall Options Held
79.3KPut Options Held
20.3K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$19.3 Million0.05% of portfolio
-
Nea Management Company, LLC Timonium, MD6.47MShares$9.7 Million0.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$7.5 Million1.15% of portfolio
-
Octagon Capital Advisors LP New York, NY4.26MShares$6.4 Million1.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$6.13 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $22M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...